|
Reconciling views on T cell receptor germline bias for MHC
|
journal
|
September 2012 |
|
Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
|
journal
|
July 2014 |
|
Automated Structure Solution with the PHENIX Suite
|
book
|
January 2008 |
|
ContPro: A web tool for calculating amino acid contact distances in protein from 3D -structures at different distance threshold
|
journal
|
July 2010 |
|
Opportunities and challenges for TCR mimic antibodies in cancer therapy
|
journal
|
April 2016 |
|
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells
|
journal
|
April 2015 |
|
Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
|
journal
|
April 2019 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Glypican-3 antibodies: A new therapeutic target for liver cancer
|
journal
|
October 2013 |
|
Targeting the MHC Ligandome by Use of TCR-Like Antibodies
|
journal
|
May 2019 |
|
Geometrical characterization of T cell receptor binding modes reveals class‐specific binding to maximize access to antigen
|
journal
|
October 2019 |
|
Improving T Cell Receptor On-Target Specificity via Structure-Guided Design
|
journal
|
February 2019 |
|
Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
|
journal
|
December 2000 |
|
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
|
journal
|
January 2013 |
|
Computational Design of the Affinity and Specificity of a Therapeutic T Cell Receptor
|
journal
|
February 2014 |
|
Targeting a neoantigen derived from a common TP53 mutation
|
journal
|
March 2021 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire
|
journal
|
February 2016 |
|
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
|
journal
|
March 1996 |
|
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity
|
journal
|
November 2015 |
|
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
|
journal
|
November 2018 |
|
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
|
journal
|
February 2018 |
|
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies
|
journal
|
February 2018 |
|
MoRDa , an automatic molecular replacement pipeline
|
journal
|
August 2015 |
|
A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis
|
journal
|
December 2006 |
|
Epidemiology and surveillance for hepatocellular carcinoma: New trends
|
journal
|
February 2020 |
|
Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells
|
journal
|
August 2013 |
|
Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid.
|
journal
|
May 1986 |
|
How tcrs bind Mhcs, Peptides, and Coreceptors
|
journal
|
April 2006 |
|
Structural analysis of glycoproteins: building N-linked glycans with Coot
|
journal
|
April 2018 |
|
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
|
journal
|
September 2019 |
|
Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells
|
journal
|
December 2008 |
|
Glypican 3 Expression in Human Nonneoplastic, Preneoplastic, and Neoplastic Tissues
|
journal
|
June 2008 |
|
TCRs with high affinity for foreign pMHC show self-reactivity
|
journal
|
December 2002 |
|
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
|
journal
|
March 2011 |
|
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
|
journal
|
September 2015 |
|
Genetic variation in MHC proteins is associated with T cell receptor expression biases
|
journal
|
August 2016 |
|
Towards automated crystallographic structure refinement with phenix.refine
|
journal
|
March 2012 |
|
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
|
journal
|
June 2017 |
|
Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
|
journal
|
January 2017 |
|
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
|
journal
|
December 2016 |
|
High-Affinity TCRs Generated by Phage Display Provide CD4 + T Cells with the Ability to Recognize and Kill Tumor Cell Lines
|
journal
|
October 2007 |
|
Understanding the complexity and malleability of T-cell recognition
|
journal
|
January 2015 |
|
Why must T cells be cross-reactive?
|
journal
|
August 2012 |
|
MolProbity: More and better reference data for improved all-atom structure validation: PROTEIN SCIENCE.ORG
|
journal
|
November 2017 |
|
CD8 + T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress
|
journal
|
September 2018 |
|
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
|
journal
|
November 2019 |
|
Glypicans in growth control and cancer
|
journal
|
March 2001 |
|
Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system
|
journal
|
March 2014 |
|
Deregulation of HLA-I in cancer and its central importance for immunotherapy
|
journal
|
August 2021 |
|
Attenuated T Cell Responses to a High-Potency Ligand In Vivo
|
journal
|
September 2010 |
|
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias
|
journal
|
May 2014 |
|
Two Different T Cell Receptors use Different Thermodynamic Strategies to Recognize the Same Peptide/MHC Ligand
|
journal
|
February 2005 |
|
T cell receptor cross-reactivity expanded by dramatic peptide–MHC adaptability
|
journal
|
September 2018 |
|
SHP-1 phosphatase activity counteracts increased T cell receptor affinity
|
journal
|
February 2013 |
|
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
|
journal
|
August 2013 |
|
T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
|
journal
|
March 2015 |
|
CD28 Costimulation: From Mechanism to Therapy
|
journal
|
May 2016 |
|
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|
journal
|
March 2012 |